GSE112645
SOXC factors as suppressors modulate Rho activity to promote neuronal reprogramming of human glioblastoma cells
Genomic targeted genes of NGN2 in U251 cell line Overall design: ChIP-seq for NEUROG2 (4 input datasets, 8 immunoprecipitation datasets) in U-251 Glioblastoma cells at 1,3 or 5 days post treatment of chemicals (Forskolin and Dorsomorphin) (DPT).